Predictors of treatment delay among drug resistant tuberculosis patients in Uganda

Several DR-TB patients experienced treatment delay. The delay was significant among patients diagnosed as RR-TB and those with TB treatment history of recurrent TB. This highlights the need for heightened vigilance among healthcare workers when managing DR-TB patients with a history of past TB treatment and those diagnosed as RR-TB to minimize delays. Furthermore, future research should investigate a comprehensive list of variables influencing the timing of treatment initiation after diagnosis. An in-depth understanding of the effects of these factors can inform targeted interventions to optimize treatment strategies for improved DR-TB patient outcomes.

Authors

Institutions

Publication Details

Journal
BMC Infectious Diseases
Published
2024-12-20
DOI
https://doi.org/10.1186/s12879-024-10339-7
Citations
1
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Predictors of treatment delay among drug resistant tuberculosis patients in Uganda

L. J. Charles, Luzze Henry, Nabukenya Diana Kasozi, Asiimwe JohnBosco
1 citations
BMC Infectious Diseases
Tuberculosis Research and Epidemiology
0.39
article

Predictors of treatment delay among drug resistant tuberculosis patients in Uganda

L. J. Charles, Luzze Henry, Nabukenya Diana Kasozi, Asiimwe JohnBosco
article en
1 citations

Abstract

Several DR-TB patients experienced treatment delay. The delay was significant among patients diagnosed as RR-TB and those with TB treatment history of recurrent TB. This highlights the need for heightened vigilance among healthcare workers when managing DR-TB patients with a history of past TB treatment and those diagnosed as RR-TB to minimize delays. Furthermore, future research should investigate a comprehensive list of variables influencing the timing of treatment initiation after diagnosis. An in-depth understanding of the effects of these factors can inform targeted interventions to optimize treatment strategies for improved DR-TB patient outcomes.

BMC Infectious DiseasesVol. 24(1)
Ministry of Health (UG), Makerere University (UG)
Good health and well-being
Openalex Percentile: Top 34%
Tuberculosis Research and Epidemiology
0.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.